Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peroxisome proliferator-activated receptors (PPARs) are a group of nuclear hormone receptors that function as ligand-activated transcription factors. They regulate lipid metabolism, glucose homeostasis, cellular differentiation, proliferation, and inflammation. The PPAR family consists of three main isotypes: PPAR-alpha, PPAR-delta/beta, and PPAR-gamma. They form heterodimers with RXR and bind to PPREs to modulate gene expression. Dysregulation is implicated in metabolic syndrome, type 2 diabetes, atherosclerosis, and cancer.
PPARs form heterodimers with RXR, bind to PPREs on target gene promoters, and modulate transcription by recruiting coactivators or corepressors.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peroxisome Proliferator-Activated Receptors (PPARs).